Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy

K. Zachova, P. Kosztyu, J. Zadrazil, K. Matousovic, K. Vondrak, P. Hubacek, BA. Julian, Z. Moldoveanu, Z. Novak, K. Kostovcikova, M. Raska, J. Mestecky

. 2020 ; 11 (-) : 267. [pub] 20200228

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012847

IgA nephropathy (IgAN) is the dominant type of primary glomerulonephritis worldwide. However, IgAN rarely affects African Blacks and is uncommon in African Americans. Polymeric IgA1 with galactose-deficient hinge-region glycans is recognized as auto-antigen by glycan-specific antibodies, leading to formation of circulating immune complexes with nephritogenic consequences. Because human B cells infected in vitro with Epstein-Barr virus (EBV) secrete galactose-deficient IgA1, we examined peripheral blood B cells from adult IgAN patients, and relevant controls, for the presence of EBV and their phenotypic markers. We found that IgAN patients had more lymphoblasts/plasmablasts that were surface-positive for IgA, infected with EBV, and displayed increased expression of homing receptors for targeting the upper respiratory tract. Upon polyclonal stimulation, these cells produced more galactose-deficient IgA1 than did cells from healthy controls. Unexpectedly, in healthy African Americans, EBV was detected preferentially in surface IgM- and IgD-positive cells. Importantly, most African Blacks and African Americans acquire EBV within 2 years of birth. At that time, the IgA system is naturally deficient, manifested as low serum IgA levels and few IgA-producing cells. Consequently, EBV infects cells secreting immunoglobulins other than IgA. Our novel data implicate Epstein-Barr virus infected IgA+ cells as the source of galactose-deficient IgA1 and basis for expression of relevant homing receptors. Moreover, the temporal sequence of racial-specific differences in Epstein-Barr virus infection as related to the naturally delayed maturation of the IgA system explains the racial disparity in the prevalence of IgAN.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012847
003      
CZ-PrNML
005      
20210507102248.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2020.00267 $2 doi
035    __
$a (PubMed)32184780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zachova, Katerina $u Department of Immunology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czechia
245    10
$a Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy / $c K. Zachova, P. Kosztyu, J. Zadrazil, K. Matousovic, K. Vondrak, P. Hubacek, BA. Julian, Z. Moldoveanu, Z. Novak, K. Kostovcikova, M. Raska, J. Mestecky
520    9_
$a IgA nephropathy (IgAN) is the dominant type of primary glomerulonephritis worldwide. However, IgAN rarely affects African Blacks and is uncommon in African Americans. Polymeric IgA1 with galactose-deficient hinge-region glycans is recognized as auto-antigen by glycan-specific antibodies, leading to formation of circulating immune complexes with nephritogenic consequences. Because human B cells infected in vitro with Epstein-Barr virus (EBV) secrete galactose-deficient IgA1, we examined peripheral blood B cells from adult IgAN patients, and relevant controls, for the presence of EBV and their phenotypic markers. We found that IgAN patients had more lymphoblasts/plasmablasts that were surface-positive for IgA, infected with EBV, and displayed increased expression of homing receptors for targeting the upper respiratory tract. Upon polyclonal stimulation, these cells produced more galactose-deficient IgA1 than did cells from healthy controls. Unexpectedly, in healthy African Americans, EBV was detected preferentially in surface IgM- and IgD-positive cells. Importantly, most African Blacks and African Americans acquire EBV within 2 years of birth. At that time, the IgA system is naturally deficient, manifested as low serum IgA levels and few IgA-producing cells. Consequently, EBV infects cells secreting immunoglobulins other than IgA. Our novel data implicate Epstein-Barr virus infected IgA+ cells as the source of galactose-deficient IgA1 and basis for expression of relevant homing receptors. Moreover, the temporal sequence of racial-specific differences in Epstein-Barr virus infection as related to the naturally delayed maturation of the IgA system explains the racial disparity in the prevalence of IgAN.
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    12
$a rasové skupiny $7 D044469
650    _2
$a infekce virem Epsteina-Barrové $x epidemiologie $7 D020031
650    _2
$a galaktosa $7 D005690
650    _2
$a IgA nefropatie $x epidemiologie $x virologie $7 D005922
650    _2
$a virus Epsteinův-Barrové $x fyziologie $7 D004854
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin A $x metabolismus $7 D007070
650    _2
$a kojenec $7 D007223
650    _2
$a prevalence $7 D015995
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kosztyu, Petr $u Department of Immunology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Zadrazil, Josef $u Department of Internal Medicine III Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Matousovic, Karel $u Department of Medicine, Second Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czechia
700    1_
$a Vondrak, Karel $u Department of Pediatrics, Second Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Hubacek, Petr $u Department of Medical Microbiology, Second Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czechia
700    1_
$a Julian, Bruce A $u Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
700    1_
$a Moldoveanu, Zina $u Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States
700    1_
$a Novak, Zdenek $u Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, United States
700    1_
$a Kostovcikova, Klara $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Raska, Milan $u Department of Immunology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czechia $u Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States
700    1_
$a Mestecky, Jiri $u Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States $u Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 11, č. - (2020), s. 267
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32184780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102248 $b ABA008
999    __
$a ok $b bmc $g 1651091 $s 1133226
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 11 $c - $d 267 $e 20200228 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace